BioVision, Inc., was founded in 1999 and aims to provide innovative, high-quality assay kits, recombinant proteins, antibodies and other innovative research tools to accelerate drug discovery in disease-related areas like cancer, diabetes, obesity, Alzheimer's disease, etc. The portfolio comprises products for studying apoptosis, metabolism, cell proliferation, cellular stress, cell damage and repair, diabetes, obesity and metabolic syndrome, as well as stem cell biology, gene regulation and signal transduction.
A large number of apoptosis assays has been developed for the detection at the early, middle and late stages of the apoptotic cascade, and for the analysis of apoptotic events that occur in different areas of the cell, including the plasma membrane, cytoplasm, mitochondria and nucleus.
Cell Proliferation & Cytotoxicity
Cell-based assays for analyzing cell growth regulation in response to growth factors, cytokines, mitogens, nutrients, chemicals, etc. are offered. They allow for the fast and sensitive quantification of cell proliferation and viability.
The offering of cell metabolism assays comprises sensitive assays for all types of molecules involved in the metabolic pathways of amino acids and carbohydrates.
The lipid metabolism assays include tools and assays for the analysis of e.g. cholesterol, fatty acids, cholesteryl ester transfer protein (CETP), or plasma phospholipid transfer protein (PLTP).